Dachaigh › Schizophrenia › Georgia
Sgrùdaidhean clionaigeach Schizophrenia ann an Georgia
Tha 29 sgrùdaidhean airson Schizophrenia a’ lorg phàirtichean aig làraichean ann an Georgia.
Bailtean ann an Georgia
Teacsa sgrùdaidh oifigeil (Beurla)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
A’ fastadhÌre 4
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05648591A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
A’ fastadhÌre 3
Aoisean 13 gu 17 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Local Institution - 0049, Austell
- Local Institution - 0044, Marietta
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
A’ fastadhÌre 3
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
A’ fastadhÌre 1
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel ACMR, Atlanta
- Cenexel iResearch Atlanta, Decatur
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07191483Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
A’ fastadhÌre 4
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
A’ fastadhÌre 4
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 4 Cèit 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 40 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Màrt 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
A’ fastadhÌre 2
Aoisean 21 gu 55 · Gach gnè · Air ùrachadh 26 Dùbh 2025 · NCT06502964Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
A’ fastadh
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 5 Gearr 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 19 Dùbh 2024 · NCT05184335Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.